WM
William S Marth
President and CEODirector

William S Marth insider trades: Albany Molecular Research (AMRI) stock purchases

President and CEO, Albany Molecular Research Last trade May 16, 2016 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2012
3
Companies
last trade 2016

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where William reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 16, 2016AMRI↑ Buy$161K
Jun 4, 2015AMRI↑ Buy$200K
Mar 5, 2015AMRI↑ Buy$354K
Nov 10, 2014AMRI↑ Buy$510K
May 12, 2014AMRI↑ Buy$462K
Dec 3, 2013AMRI↑ Buy$323K
Nov 22, 2013AMRI↑ Buy$231K
Jun 3, 2013AMRI↑ Buy$102K
Dec 3, 2012AMRI↑ Buy$50K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About William S Marth's insider trades

William S Marth is President and CEO at Albany Molecular Research (AMRI). Since Dec 3, 2012, William has reported 9 open-market purchases worth $2.4M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (17 filings), shares withheld for taxes (5 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMRI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.